These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 34877208)
1. Generic Anticancer Drugs of the Jan Aushadhi Scheme in India and Their Branded Counterparts: The First Cost Comparison Study. George T; Baliga MS Cureus; 2021 Nov; 13(11):e19231. PubMed ID: 34877208 [TBL] [Abstract][Full Text] [Related]
2. A Cost Analysis of the Jan Aushadhi Scheme in India. Mukherjee K Int J Health Policy Manag; 2017 May; 6(5):253-256. PubMed ID: 28812812 [TBL] [Abstract][Full Text] [Related]
3. Pharmacoeconomic Appraisal of Treating Head and Neck Cancer with Various Chemotherapy and Chemoirradiation Regimens Using Branded and Jan-aushadhi Drugs in India. Krishna A; Jayachandran M; Sacheendran D; George T; Palatty PL; Baliga MS Indian J Otolaryngol Head Neck Surg; 2023 Sep; 75(3):1782-1791. PubMed ID: 37636797 [TBL] [Abstract][Full Text] [Related]
4. A study on the price variability of branded medicines and Jan aushadi versions of selected commonly prescribed psychiatric medications in India using a cost-comparative approach and a passive evaluation of the Jan aushadhi scheme in India. Vasisht PV J Family Med Prim Care; 2024 May; 13(5):2054-2059. PubMed ID: 38948584 [TBL] [Abstract][Full Text] [Related]
5. Cost analysis of various branded versus generic chemotherapeutic agents used for the treatment of early breast cancer- a deep insight from India. Kashyap A; Balaji MN; Chhabra M; Rashid M; Muragundi PM Expert Rev Pharmacoecon Outcomes Res; 2020 Aug; 20(4):355-361. PubMed ID: 31248303 [TBL] [Abstract][Full Text] [Related]
6. Perceived Utility of Jan Aushadhi Outlets and Awareness of Generic Medicines at the Andaman and Nicobar Islands: A Cross-Sectional Study. Chaturvedi A; Dubey AK; Naveen A; Sravani MR Cureus; 2024 Apr; 16(4):e57630. PubMed ID: 38711720 [TBL] [Abstract][Full Text] [Related]
7. Health economics and effectiveness analysis of generic anti-diabetic medication from jan aushadhi: An ambispective study in community pharmacy. Chaudhary RK; Philip MJ; Santhosh A; Karoli SS; Bhandari R; Ganachari MS Diabetes Metab Syndr; 2021; 15(6):102303. PubMed ID: 34626923 [TBL] [Abstract][Full Text] [Related]
8. A Cost Variation Analysis of Drugs Available in the Indian Market for the Management of Thromboembolic Disorders. Ray A; Najmi A; Khandelwal G; Sadasivam B Cureus; 2020 May; 12(5):e7964. PubMed ID: 32523821 [TBL] [Abstract][Full Text] [Related]
9. Why the Jan Aushadhi Scheme Has Lost Its Steam in India? Thawani V; Mani A; Upmanyu N J Pharmacol Pharmacother; 2017; 8(3):134-136. PubMed ID: 29081624 [TBL] [Abstract][Full Text] [Related]
10. A cost analysis and availability scenario of drugs and oral care products prescribed for common oral conditions with reference to the current Indian market prices, Jan Aushadhi, and the state medical commissions. Gauthaman J J Family Med Prim Care; 2022 May; 11(5):2134-2138. PubMed ID: 35800502 [TBL] [Abstract][Full Text] [Related]
11. Improving access to medicines by popularising generics: a study of 'India's People's Medicine' scheme in two districts of Maharashtra. Lavtepatil S; Ghosh S BMC Health Serv Res; 2022 May; 22(1):643. PubMed ID: 35562697 [TBL] [Abstract][Full Text] [Related]
12. Opinion of primary care physicians regarding prescription of generic drugs: A Cross-sectional study. Charan J; Saxena D; Chaudhri M; Dutta S; Kaur RJ; Bhardwaj P J Family Med Prim Care; 2021 Mar; 10(3):1390-1398. PubMed ID: 34041184 [TBL] [Abstract][Full Text] [Related]
13. A cost analysis of the psychotropic medicines sold in the jan aushadhi generic drug stores in India. Uvais NA Asian J Psychiatr; 2018 Mar; 33():40-41. PubMed ID: 29518751 [No Abstract] [Full Text] [Related]
14. Generic versus branded medicines: An observational study among patients with chronic diseases attending a public hospital outpatient department. Das M; Choudhury S; Maity S; Hazra A; Pradhan T; Pal A; Roy RK J Nat Sci Biol Med; 2017; 8(1):26-31. PubMed ID: 28250671 [TBL] [Abstract][Full Text] [Related]
15. Cost comparison and economic implications of commonly used originator and generic chemotherapy drugs in India. Lopes Gde L Ann Oncol; 2013 Sep; 24 Suppl 5():v13-6. PubMed ID: 23975699 [TBL] [Abstract][Full Text] [Related]
16. A comparative evaluation of price and quality of some branded versus branded-generic medicines of the same manufacturer in India. Singal GL; Nanda A; Kotwani A Indian J Pharmacol; 2011 Apr; 43(2):131-6. PubMed ID: 21572645 [TBL] [Abstract][Full Text] [Related]
17. Suboptimal prescribing behaviour associated with clinical software design features: a retrospective cohort study in English NHS primary care. MacKenna B; Curtis HJ; Walker AJ; Bacon S; Croker R; Goldacre B Br J Gen Pract; 2020 Sep; 70(698):e636-e643. PubMed ID: 32784218 [TBL] [Abstract][Full Text] [Related]
18. Cost and price of comparable branded and generic pharmaceuticals. Bloom BS; Wierz DJ; Pauly MV JAMA; 1986 Nov; 256(18):2523-30. PubMed ID: 3773152 [TBL] [Abstract][Full Text] [Related]
19. Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study. Desai RJ; Sarpatwari A; Dejene S; Khan NF; Lii J; Rogers JR; Dutcher SK; Raofi S; Bohn J; Connolly J; Fischer MA; Kesselheim AS; Gagne JJ BMJ; 2018 Apr; 361():k1180. PubMed ID: 29615391 [TBL] [Abstract][Full Text] [Related]
20. Generic drugs: Review and experiences from South India. Mathew P J Family Med Prim Care; 2015; 4(3):319-23. PubMed ID: 26286613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]